Download File (Pdf)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Hexavalent Dtap/IPV/Hib/Hepb Combination Vaccine: Information for Healthcare Practitioners About the Neonatal Selective
The hexavalent DTaP/IPV/Hib/HepB combination vaccine Information for healthcare practitioners about the neonatal selective immunisation programme for babies at risk of hepatitis B The Hexavalent DTaP/IPV/Hib/HepB combination vaccine: Information for Healthcare Practitioners (selective programme) About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, research, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. We are an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy. We provide government, local government, the NHS, Parliament, industry and the public with evidence-based professional, scientific and delivery expertise and support. Public Health England Wellington House 133-155 Waterloo Road London SE1 8UG Tel: 020 7654 8000 www.gov.uk/phe Twitter: @PHE_uk Facebook: www.facebook.com/PublicHealthEngland For queries relating to this document, please contact: [email protected] © Crown copyright 2020 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0. To view this licence, visit OGL. Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. First published November 2017 This updated version published February -
Algiers Economic Opportunity Analysis
Algeria Entrepreneurship & Employment Project Algiers Economic Opportunity Analysis Version: April 13, 2020 By Eleanor Sohnen Methodology designed by Dr. Catherine Honeyman Research conducted by Mehdi Bentoumi Contents Contents . 2 Algeria Entrepreneurship Executive Summary . 3 & Employment Industry sector priorities and rationale . 4 Project Launched: Mapping Supply Chains and Identifying Needs and Opportunities . 5 October 2019 Funder: U.S. Agribusiness/Food Processing . 5 Department of State Middle East Partnership Initiative Supply Chain Map of the Sector . 7 (MEPI) Analysis of needs to support SME business growth in the sector . 8 Analysis of opportunities in the sector . 8 Local partners: Pharmaceuticals . 8 ◆ Algerian Center for Social Supply Chain Map of the Sector . 10 Entrepreneurship (ACSE) Analysis of needs to support SME business growth in the sector . 11 ◆ MBI (Setif) Analysis of opportunities in the sector . 11 Information and Communications Technology (ICT) . 11 Process Map Example: Mobile Application Development . .12 Analysis of needs to support SME business growth in the sector . .12 Analysis of opportunities in the sector . 12 Conclusions . 13 Analysis of needs to support SME business growth across the three sectors . 13 Analysis of opportunities across the three sectors . 13 Demand-driven training and recruitment . 13 New business creation to supply B2B products and services across the three sectors . .15 Policy Issues . 17 Next Steps . 17 SME priority partners . 17 Annex A: Economic Opportunity Analysis Methodology . 18 Annex B: Sector Analysis–Algiers . 28 2 World Learning Algeria Algiers Economic Opportunity Analysis - Version April 13, 2020 Executive Summary The wilaya of Algiers, with a population of 3.2 million as of the end of 2017, is the country’s admin- istrative, political, and economic capital. -
India - the Netherlands Virtual Summit Friday, April 9, 2021
India - The Netherlands Virtual Summit Friday, April 9, 2021 Joint Statement on India-The Netherlands Virtual Summit - Towards a Strategic Partnership on Water Shri Narendra Modi, Prime Minister of the Republic of India, and H.E. Mr. Mark Rutte, Prime Minister of the Netherlands, co-chaired a Virtual Summit between India and the Netherlands on April 9, 2021. 2. The two Prime Ministers recalled their previous meetings in 2015, 2017 and 2018 as well as the successful visit of the King and the Queen of the Netherlands to India in 2019 and welcomed the steadfast development of bilateral relations that are underpinned by the shared values of democracy, rule of law, pluralism, equality, freedom of speech and respect for human rights and the historic bonds of friendship between the two countries. They held an in- depth exchange of views on further deepening the bilateral relationship in wide-ranging areas of cooperation including trade and economy, water management and agriculture sector, smart cities and urban mobility, science & technology cooperation, public health & health care and space. 3. In the context of new geopolitical and geoeconomic realities, they also shared views on regional and global issues of mutual interest including post-Covid economic recovery, climate change and the Indo-Pacific. They reiterated their strong commitment to a rules- based multilateral order for ensuring international peace, stability and prosperity. Fight against COVID-19 Pandemic 4. The two leaders commended the selfless contribution of healthcare workers and other frontline staff across the globe in the fight against the pandemic. Both leaders reiterated their commitment to ensure equitable and affordable access to Covid19 vaccines to all countries and agreed to cooperate in this regard. -
The Journal of William Morris Studies
The Journal of William Morris Studies volume xx, number 3, winter 2013 Editorial – Fears and Hopes Patrick O’Sullivan 3 William Morris and Robert Browning Peter Faulkner 13 Two Williams of one medieval mind: reading the Socialist William Morris through the lens of the Radical William Cobbett David A. Kopp 31 Making daily life ‘as useful and beautiful as possible’: Georgiana Burne-Jones and Rottingdean, 1880–1904 Stephen Williams 47 William Morris: An Annotated Bibliography 2010–2011 David and Sheila Latham 66 Reviews. Edited by Peter Faulkner Michael Rosen, ed, William Morris, Poems of Protest (David Goodway) 99 Ingrid Hanson, William Morris and the Uses of Violence, 1856–1890 (Tony Pinkney) 103 The Journal of Stained Glass, vol. XXXV, 2011, Burne-Jones Special Issue. (Peter Faulkner) 106 the journal of william morris studies . winter 2013 Rosie Miles, Victorian Poetry in Context (Peter Faulkner) 110 Talia SchaVer, Novel Craft (Phillippa Bennett) 112 Glen Adamson, The Invention of Craft (Jim Cheshire) 115 Alec Hamilton, Charles Spooner (1862–1938) Arts and Crafts Architect (John Purkis) 119 Clive Aslet, The Arts and Crafts Country House: from the archives of Country Life (John Purkis) 121 Amy Woodhouse-Boulton, Transformative Beauty. Art Museums in Industrial Britain; Katherine Haskins, The Art Journal and Fine Art Publishing in Vic- torian England, 1850–1880 (Peter Faulkner) 124 Jonathan Meades, Museum without walls (Martin Stott) 129 Erratum 133 Notes on Contributors 134 Guidelines for Contributors 136 issn: 1756–1353 Editor: Patrick O’Sullivan ([email protected]) Reviews Editor: Peter Faulkner ([email protected]) Designed by David Gorman ([email protected]) Printed by the Short Run Press, Exeter, UK (http://www.shortrunpress.co.uk/) All material printed (except where otherwise stated) copyright the William Morris Society. -
In 2020, India Dealt with the First Wave of COVID-19 Pandemic With
PREFACE n 2020, India dealt with the first wave of COVID-19 pandemic with collective measures, Iscientific approach, and awareness. Undoubtedly the second wave of the pandemic is testing our patience and the extent to which we can all tolerate its fangs. The impact of the second wave has seen shortage of medical oxygen across the nation. But, the intelligent use of technology and well-planned resource allocation to tackle the new wave of the pandemic has been dealt with at a war-footing. The current edition, COVID 2021: Nation’s S&T Efforts Against COVID-19, has been compiled to inform our readers and strengthen the usefulness of any published information. This edition contains compilation and coverage of information related to the capacity enhancement of medical oxygen, start-up spotlights, research contributions, and so on. To bridge the gap among scientific contributions, leadership and administrative efforts, and the perspective of the general public, Vigyan Prasar is continuously reaching out to its audiences in the shape of a regular e-newsletter, taking its mandate of science communication, popularisation and extension to the next level. Our effort is firmly based on the fact that “Science gathers knowledge faster than society gathers wisdom”. The steady increase in the number of recoveries and the significant and continuous decrease in positivity rate provide us the much-needed assurance that this may be the outcome of improving the health infrastructure and making health the cornerstone at the policy level. We wish an engaging reading to our audiences across all strata of the society and look forward to suggestions and feedback at [email protected]. -
UNICEF Pentavalent-Hexa 2021+ Pre-Tender Industry Consultation
UNICEF Pentavalent-Hexa 2021+ Pre-Tender Industry Consultation 19th SEPTEMBER 2019 1 Presentation Outline 1. Context ▪ Gavi Board decision ▪ Hexa strategic alignment ▪ Value Based Assessment 2. Demand scenarios and assumptions 3. Pentavalent Tender: ▪ Objectives ▪ Scope ▪ Duration ▪ Modality 4. Summary of feedback and response to questionnaire 5. Timelines 1. CONTEXT Gavi Board decision Hexa strategic alignment Value Based Assessment 3 Gavi Board November 2018 – Decisions IPV Post-2020 DTP booster VIS 2018 VIS 2018 + Hexavalent as immunisation option • Approved support for D, T & P vaccines (Td, DTwP, pentavalent) to be used as booster doses beginning in 2021 • Approved support for inactivated poliovirus vaccine (IPV), with country financing arrangements subject to alignment with the final parameter setting for Gavi 5.0 at the June 2019 Board meeting* • Approved in principle support of wP-Hexavalent vaccine, subject to a vaccine being licenced, recommended for use by WHO, WHO pre-qualified and that market attributes support the successful implementation of Hexavalent The development of capacity for standalone IPV remains the main priority for Gavi Alliance as part of the effort to eradicate polio All Gavi Board decisions are “subject to the availability of funding for the 2021-2025 period and alignment with the final parameter setting for Gavi 5.0 at the June 2019 Board meeting.” *Gavi's Board approved IPV co-financing arrangements post-2020 in its June 2019 session 4 Conditions to open a funding window for Hexavalent Condition 1: Hexavalent vaccines that are candidates for Gavi support should achieve IPV immunogenicity targets as per WHO’s SAGE recommendations. Condition 2: Hexavalent vaccines are priced in line with value-based principles. -
Event Summary Report
1 EVENT SUMMARY REPORT INDIA-NIGERIA: FACING THE COVID-19 PANDEMIC TOGETHER Date: March 30, 2021 Time: 1030-1315 (WAT) Venue: Cisco Webex Virtual Platform Recording Link: https://www.youtube.com/watch?v=L8FpbwhgUdA 1. INTRODUCTION 1.1 The webinar was the first event to be co-hosted by the Gusau Institute (GI) in Nigeria and the Manohar Parrikar Institute for Defence Studies and Analyses (MP-IDSA) in India, and it concentrated on ways to join forces in the fight against COVID-19. Other areas of potential and/ or expanded collaboration were also highlighted during the deliberations. 1.2 The event was divided into two sessions that focused on identifying areas of cooperation between Nigeria and India in controlling the COVID-19 pandemic, and emerging India-Africa cooperation, respectively. The discussions were preceded by an inaugural session co-chaired by the founder of the GI, and the Director General of MP-IDSA, who also led the rest of the programme. (Note: Short profiles of all the participants are attached as Annexure A.) 2. PROGRAMME HIGHLIGHTS 2.1 INAUGURAL SESSION 2.1.1 Opening Remarks by Amb. Sujan R. Chinoy Director General, MP-IDSA https://www.youtube.com/watch?v=L8FpbwhgUdA (0:45-12:34) 2.1.1.1 Copy of the DG’s remarks follows: Lt. Gen. Aliyu Gusau Mohammed, Founder, Gusau Institute, Amb Abhay Thakur, High Commissioner of India to Nigeria, Mr. Boss Mustapha, Secretary to the Government of the Federation (SGF) & Chairman, Presidential Task Force on COVID-19, Experts from Gusau Institute, Distinguished participants, Good afternoon, 2 Today, we have gathered for the first bilateral event, albeit in virtual mode, between the Manohar Parrikar Institute for Defence Studies and Analyses and the Gusau Institute of Nigeria. -
Press Release
Press release 21/04/2021 Club Med officially opens its brand-new ecochic resort Club Med Exclusive Collection in one of most exceptional destinations in the Indian Ocean: the Seychelles. From right to left: Wavel Ramkalawan, President of Seychelles, Henri Giscard d'Estaing, Dominique Mas, Ambassador of France to Seychelles. Henri Giscard d'Estaing, President of Club Med, officially inaugurated today the brand new Club Med Exclusive Collection Resort in the Seychelles in the presence of: - Mr. Wavel Ramkalawan, President of the Republic of Seychelles and his wife - Mr. Ahmed Afif, Vice-President of the Republic of Seychelles - Mr. Sylvestre Radegonde, Minister of Foreign Affairs and Tourism - Mr. Roger Mancienne, Speaker of the National Assembly of Seychelles - Mr. Dominique Mas, Ambassador of France to Seychelles and many elected officials, members of the diplomatic corps, decision makers, partners, investors, personalities and local media who were also able to attend the event. ’’ On this occasion, Sylvestre Radegonde, Minister of Foreign Affairs and Tourism of the Republic of Seychelles, said: The arrival of this prestigious French company in our country also marks the revival of our tourism industry after months of inactivity due to the Covid-19 pandemic which paralyzed the tourism sector, on which our economy depends very largely. The opening of Club Med Seychelles couldn't be more in line with our country's economic calendar. Club Med's international dimension fits in perfectly with the upscale approach you have promoted and which we are reaping the benefits of today with this resort. It is entirely consistent with our destination and the image it enjoys in the global market. -
Case Studies Controversies in Vaccination
European Review, Vol. 21, No. S1, S56–S61 r 2013 Academia Europæa. The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution license ,http://creativecommons.org/licenses/by/3.0/.. doi:10.1017/S1062798713000227 Session 3 – Case Studies Controversies in Vaccination ROMAN PRYMULA University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. E-mail: [email protected] Infectious diseases still jeopardize human health and even lives. In spite of the variety of advanced treatment methods, prevention is considered to be the most effective way to fight infections, and vaccination, no doubt, is one of the most effective preventive measures in the history of mankind. The vaccine controversy is based on a dispute over morality, ethics, effectiveness, and/or safety. There is no 100% safe or effective vaccine; however, benefits clearly overweigh risks. Ironically, as the numbers of cases of vaccine- preventable infectious diseases are falling, the controversies relating to vaccine safety are growing. Vaccines are generally victims of their own success. Controversies can afflict the positive acceptance of immunization, decrease the coverage and uptake and finally threaten the health of children and adults. The advent of vaccination has proven to be one of the most effective preventive measures in the history of medicine. Vaccines play a significant role in the prevention of debili- tating and, in many cases, life-threatening infectious diseases. Vaccines also provide important benefits in terms of reducing or avoiding costs associated with illness, both direct and indirect. In spite of the absence of any kind of ideal global healthcare system and lack of resources, the World Health Organisation (WHO) and the United Nations Children’s Fund (UNICEF) were able, in 1974, to establish a major global project called the Expanded Programme on Immunization (EPI). -
Agenda & Speaker Biographies
2015 Ibrahim Forum Agenda & Speaker Biographies AFRICAN URBAN DYNAMICS Saturday, 21 November MO IBRAHIM FOUNDATION 2015 Ibrahim Forum Agenda & Speaker Biographies AFRICAN URBAN DYNAMICS Saturday, 21 November Accra, 21 November 2 AFRICAN URBAN DYNAMICS 9:00-9:30 Welcome addresses The discussions will be moderated by Zeinab Badawi 9:30-11:00 Opening session Urban trends: Setting the scene Chair: Ngaire Woods, Dean of the Blavatnik School of Government, University of Oxford Akinwumi Adesina, President of the African Development Bank (AfDB) Aisa Kirabo Kacyira, Deputy Executive Director, Assistant Secretary-General of UN-Habitat Kumi Naidoo, International Executive Director of Greenpeace Henri-Bernard Solignac-Lecomte, Head of Unit, Europe, Middle East & Africa for the OECD Development Centre Alfred Vanderpuije, Mayor of Accra Although still a mostly rural continent, urban areas in Africa are now growing at a much quicker pace than any other continent has before. In the next 35 years, the African continent is expected to accommodate 866 million new urban dwellers, which is roughly the same amount (915 million) as Europe, USA and Japan combined have managed in 265 years, with much greater resources. Moreover, this immediate challenge is amplified by issues that are specific to Africa. African urbanisation is mainly driven by natural population growth, rather than by rural-urban migration. 2015 Ibrahim Forum 3 Up until now, it has occurred without, or with only a weak link to, industry-driven, job-creating economic growth. Also, on a continent struggling with topographic and natural constraints, and as host to many current conflicts, the demands of the 21st century include climate change, growing migration flows and worsening security threats, all of which exacerbate the urbanisation challenge. -
II to Lok Sabha Unstarred Question No. 251 Visits by Prime Minister
Annexure- II to Lok Sabha Unstarred Question No. 251 Visits by Prime Minister -Nil- Visits by External Affairs Minister S. Countries Period of Details of discussions held and outcome thereof No. visited visit 1 Russia September EAM attended the meeting of Council of SCO Foreign Ministers. 09-10, 2020 Following the meeting, SCO Foreign Ministers adopted an Information Statement. On the sidelines of the SCO meeting, EAM participated in the meeting of Russia-India-China Foreign Ministers. A joint Press Release was issued after the conclusion of Russia-India-China Foreign Ministers Meeting. EAM also held a separate bilateral meeting with the Russian Foreign Minister Mr. Sergey Lavrov. EAM had meetings with the Foreign Ministers of China, Kazakhstan, Kyrgyz Republic, Tajikistan and Uzbekistan. Issues of bilateral, regional and international importance were discussed. 2 Japan October 06- EAM participated in the Second India-Australia-Japan-USA 07, 2020 Ministerial Meeting on 6 October 2020. He along with the Foreign Ministers called on Japanese Prime Minister Mr. Suga Yoshihide. EAM held separate bilateral meetings with the US Secretary of State and Australian Foreign Minister. EAM participated in the 13th India-Japan Foreign Ministers' Strategic Dialogue. The two ministers reviewed the progress made in the India-Japan Special Strategic and Global Partnership and in this context discussed cooperation in various areas, including maritime security, trade and investment, manufacturing and skill development, connectivity and infrastructure, cybersecurity etc. Japan also conveyed its agreement to be the lead partner in the connectivity pillar of the Indo-Pacific Oceans’ Initiative (IPOI), which was announced by PM Modi in November 2019. -
Immunogenicity and Safety of a Fully Liquid Dtap-IPV-Hep B-PRP-T
ccines & a V f V a o c l c i a n n a Lanata et al., J Vaccines Vaccin 2012, 3:1 r t u i o o n J Journal of Vaccines & Vaccination DOI: 10.4172/2157-7560.1000128 ISSN: 2157-7560 Research Article Open Access Immunogenicity and Safety of a Fully Liquid DTaP-IPV-Hep B-PRP-T Vaccine at 2-4-6 Months of Age in Peru Claudio Lanata1, Betzana Zambrano2, Lucie Ecker1, Isabel Amemiya1, Ana Gil1 and Eduardo Santos Lima3* 1Instituto de Investigación Nutricional, Lima, Peru 2Sanofi Pasteur, Montevideo, Uruguay 3Clinical Development, Sanofi Pasteur, Lyon, France Abstract Objectives: To assess the immunogenicity and safety of a new candidate, fully liquid, hexavalent DTaP-IPV- Hep B-PRP-T vaccine (Hexaxim™, an AcXim family vaccine) compared to a licensed hexavalent DTaP-IPV-Hep B// PRP-T vaccine (Infanrix hexa®) in Peru. Methods: Infants born to HBsAg seronegative mothers and who had not received a hepatitis B vaccine prior to entry into the study were randomized to receive either Hexaxim™ (Group 1) or Infanrix hexa® (Group 2) at 2, 4, 6 months of age. Seroprotection (SP) rate for hepatitis B (anti-HBs antibody concentration ≥10 mIU/mL) was analysed for non-inferiority (Group 1 minus Group 2) 1 month post-primary series. Anti-diphtheria and anti-polyrosil ribitol phosphate (PRP) antibody responses were analysed descriptively. Safety was analysed from parental reports. Results: Seroprotection rate for anti-HBs antibody titers ≥10 mIU/mL was high in both groups (≥99.2%) and non-inferiority was demonstrated (lower bound of the 95% CI for the difference was -4.17, above the pre-defined delta [-10%]).